Related Experiment Videos

The long noncoding RNA colon cancer-associated transcript-1/miR-490 axis regulates gastric cancer cell migration by

Baoguo Zhou1, Yuli Wang1, Jinpeng Jiang1

  • 1Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.

IUBMB Life
|January 31, 2016
PubMed

Insights

Colon cancer-associated transcript-1 (CCAT1) regulates miR-490 in gastric cancer (GC) cells, promoting tumor cell migration. This CCAT1/miR-490/hnRNPA1 axis presents potential diagnostic and therapeutic targets for GC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Colon cancer-associated transcript-1 (CCAT1) is a long noncoding RNA implicated in various cancers.
  • Its specific role and regulation in gastric carcinoma (GC) remain largely unclear.

Purpose of the Study:

  • To investigate the regulatory relationship between CCAT1 and miR-490 in GC.
  • To elucidate the functional impact of this interaction on GC cell migration.

Main Methods:

  • Expression analysis of CCAT1 and miR-490 in GC cell lines and tissues.
  • Luciferase reporter assays to confirm the binding site and regulatory interaction.
  • Cell migration assays following CCAT1 or miR-490 manipulation.
  • Analysis of hnRNPA1 expression and its correlation with CCAT1 and miR-490.

Main Results:

  • CCAT1 was significantly upregulated, while miR-490 was downregulated in GC.
  • CCAT1 and miR-490 exhibited a negative correlation in GC tissues.
  • miR-490 directly targeted CCAT1 and suppressed GC cell migration.
  • miR-490 also repressed hnRNPA1 translation, and hnRNPA1 was upregulated in GC.
  • Inhibition of miR-490 reversed CCAT1 siRNA-induced suppression of cell migration.

Conclusions:

  • The CCAT1/miR-490/hnRNPA1 axis promotes gastric cancer cell migration.
  • This axis represents a potential diagnostic biomarker and therapeutic target for GC.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
14.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K